Trademark: 87771739
Word
CANNABINOID RESEARCH INSTITUTE
Status
Registered
Status Code
700
Status Date
Tuesday, May 28, 2019
Serial Number
87771739
Registration Number
5765928
Registration Date
Tuesday, May 28, 2019
Mark Type
4000
Filing Date
Friday, January 26, 2018

Trademark Owner History
GW RESEARCH LIMITED - Original Registrant
GW Pharma Limited - Original Applicant

Classifications
41 Providing online non-downloadable electronic publications in the nature of newsletters, journals, and books in the field of cannabinoid-based medicines; arranging, conducting and organisation of educational conferences, congresses, seminars and symposiums in the field of cannabinoid-based medicines; information, advisory and consultancy services in relation to all of the aforesaid services
42 Scientific and technological services and research and design relating thereto, namely, scientific research in the field of cannabinoid-based medicines, research on the subject of pharmaceuticals, and pharmaceutical drug development services, all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical research and development services all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; research, testing and development of pharmaceutical and veterinary preparations all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; biological, clinical and medical research all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; conducting clinical trials for others all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical analysis all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; information, advisory and consultancy services in relation to all of the aforesaid services
"RESEARCH INSTITUTE"

Trademark Events
Sep 15, 2021
Teas Change Of Correspondence Received
Sep 15, 2021
Teas Change Of Domestic Representatives Address
Sep 15, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 28, 2021
Assignment Of Ownership Not Updated Automatically
May 28, 2019
Registered-Supplemental Register
Apr 24, 2019
Law Office Publication Review Completed
Apr 17, 2019
Automatic Update Of Assignment Of Ownership
Apr 12, 2019
Assigned To Lie
Mar 25, 2019
Approved For Registration Supplemental Register
Mar 25, 2019
Examiner's Amendment Entered
Mar 25, 2019
Notification Of Examiners Amendment E-Mailed
Mar 25, 2019
Examiners Amendment E-Mailed
Mar 25, 2019
Examiners Amendment -Written
Mar 11, 2019
Assigned To Examiner
Jan 23, 2019
Assigned To Examiner
Jan 22, 2019
Teas/Email Correspondence Entered
Jan 22, 2019
Correspondence Received In Law Office
Jan 22, 2019
Teas Response To Office Action Received
Jul 23, 2018
Notification Of Non-Final Action E-Mailed
Jul 23, 2018
Non-Final Action E-Mailed
Jul 23, 2018
Non-Final Action Written
Jul 23, 2018
Assigned To Examiner
Jul 16, 2018
Assigned To Examiner
Jul 16, 2018
Assigned To Examiner
Feb 8, 2018
Assigned To Examiner
Feb 7, 2018
New Application Office Supplied Data Entered In Tram
Jan 30, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24